Oncology & Cancer
Breast cancer drug shown to reduce recurrence risk
Even when the disease is caught early, breast cancer recurrence is relatively commonplace—and for survivors, the prospect can be daunting.
Jun 2, 2023
0
42
News tagged with metastatic
Medications
Black men with metastatic prostate cancer may benefit from drug combination
A drug combination that shows little overall survival benefit in white men with advanced prostate cancer has a far greater effect in Black men with the disease, according to interim results from a study led by the Duke Cancer ...
Jun 1, 2023
0
10
Oncology & Cancer
Rethinking the protein inhibitor approach to cancer therapy
A new method than enables researchers to dial up or tone down the amount of a certain metastatic protein inhibitor (BACH1) within a cell could provide a new path in cancer research that reassesses the effectiveness of protein ...
May 26, 2023
0
76
Oncology & Cancer
HER3: A key survival pathway and therapeutic target in metastatic colorectal and pancreatic cancer
A new research perspective titled "HER3- A key survival pathway and an emerging therapeutic target in metastatic colorectal cancer and pancreatic ductal adenocarcinoma" has been published in Oncotarget.
May 24, 2023
0
0
Oncology & Cancer
Bioengineering active immunotherapy for personalized cancer treatment
Breast cancer is resistant to immunotherapies; therefore, bioengineers and oncologists seek to develop a slew of therapeutic strategies to overcome this challenge. In a new report in Science Advances, Kerui Wu and colleagues ...
Oncology & Cancer
Unique insights into differences between primary and metastatic cancer by large-scale DNA data analyses
Cancer is caused by DNA changes that cause a cell to gradually change from benign to malignant. This can lead to metastases in other parts of the body. By analyzing the DNA data of more than 7,000 patients, the researchers ...
May 16, 2023
0
113
Oncology & Cancer
Researchers develop CAR T cells that fight prostate cancer in bone
Prostate cancer frequently metastasizes to the bone and is incurable. Moffitt Cancer Center researchers are working to identify new treatment options for this subset of patients. In a new article published today in Science ...
May 3, 2023
0
33
Oncology & Cancer
New test launched for men with metastatic prostate cancer
Routine diagnostic analyses of mutations in cell-free DNA in patients with metastatic prostate cancer are now possible for the first time in Sweden. The test has been developed by researchers at Karolinska Institutet, and ...
Apr 27, 2023
0
0
Oncology & Cancer
Study suggests chromosomal errors may hinder some aggressive tumors
Chromosomal errors are a hallmark of cancer cells. Defects in the genome derived from the incorrect separation of chromosomes (and the DNA packed within) in each division of cells drive tumor growth and resistance to therapy.
Apr 24, 2023
0
42
Oncology & Cancer
Guideline updated for initial management of advanced prostate cancer
For patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen deprivation therapy (ADT), and doublet therapy ...
Apr 12, 2023
0
9
